A prodrug nanoplatform via esterification of STING agonist and IDO inhibitor for synergistic cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s12274-022-4598-6
Published Online: 2022-06-29
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Syeda, Madiha Zahra
Hong, Tu
Zhang, Min
Han, Yanfei
Zhu, Xiaoling
Ying, Songmin
Tang, Longguang
Text and Data Mining valid from 2022-06-29
Version of Record valid from 2022-06-29
Article History
Received: 28 April 2022
Revised: 24 May 2022
Accepted: 28 May 2022
First Online: 29 June 2022